Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Cepheid, Cancer Genetics Appoint New Execs

Premium

Cepheid said this week that it has appointed James Post to the position of executive vice president of North American commercial operations.

Post joins Cepheid from Alere, where he most recently served as global president of acute care. Post spent ten years at Alere and its predecessor companies Inverness Medical and Biosite. Prior to Alere, he spent approximately ten years at the United States Surgical Corporation in a variety of sales and marketing positions, including vice president of sales.


Cancer Genetics said this week that Christopher Mitton has joined the company as director of national account development and sales operations.

Mitton will lead the national expansion of CGI's Expand Dx program, designed to increase outreach and patient value for community hospitals and labs by expanding their cancer diagnostic capabilities through new testing methodologies and collaborative services. He most recently led North American sales of leukemia and solid tumor molecular diagnostic tests for Qiagen, and prior to that held diagnostic sales roles with Ipsogen, Bayer Healthcare, Abbott Diagnostics, and BioChem Immunosystems.